- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01974037
Capsaicin on Salty Gustatory Cortices
Effects of Capsaicin on Salty Gustatory Cortices in Human
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Hypertension and its related complications are common health problems that can lead to multiple organ damage and death. Excessive salt intake plays an important role in the development of hypertension.
The experimental design is a randomized, double-blind, interventional study to investigate the neuroimaging changes of salty gustatory cortices under different concentration of NaCl solution with or without capsaicin intervention through brain PET/CT scan.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
Chongqing
-
Chongqing, Chongqing, China, 400042
- Daping Hospital, The Third Military Medical University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age ≥ 18 years and ≤ 65 years.
- Willing and able to provide written informed consent.
- Willing and able to comply with all study procedures.
Exclusion Criteria:
- High basic metabolic rate, tumor, epilepsia.
- Hypogeusia or loss due to neural system disease or oral and digestive disease.
- Capsaicin allergy and poor compliance.
- Recently oral diuretics and participate in other pharmacological experiment in 3 months.
- Acute infection, cancer, serious arrhythmias, drug or alcohol abuse.
- Currently have cold, fever, acidosis, dehydration, diarrhea, vomiting during the study.
- Unwilling or unable to communication due to the dysnoesia and language disorders.
- Severe neural or psychiatric diseases that would preclude fully understand and corporation in the study.
- History of allergic reaction attributed to 18F-FDG.
- Pregnancy or lactation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Capsaicin_effect subgroup 1
The volunteers allocated to the arm will perform neuroimaging detection with buccal administration of water with capsaicin.
|
Capsaicin in the concentration of 0.5 µmol/L was mixed in the test solutions in Capsaicin_effect subgroups
|
Experimental: Capsaicin_effect subgroup 2
The volunteers allocated to the arm will perform neuroimaging detection with buccal administration of 100 mmol/L NaCl with capsaicin.
|
Capsaicin in the concentration of 0.5 µmol/L was mixed in the test solutions in Capsaicin_effect subgroups
|
Experimental: Capsaicin_effect subgroup 3
The volunteers allocated to the arm will perform neuroimaging detection with buccal administration of 150 mmol/L NaCl with capsaicin.
|
Capsaicin in the concentration of 0.5 µmol/L was mixed in the test solutions in Capsaicin_effect subgroups
|
No Intervention: Capsaicin_effect subgroup 4
The volunteers allocated to the arm will perform neuroimaging detection with buccal administration of 200 mmol/L NaCl.
|
|
No Intervention: Salt_effect subgroup 1
The volunteers allocated to the arm will perform neuroimaging detection with buccal administration of water.
|
|
Experimental: Salt_effect subgroup 2
The volunteers allocated to the arm will perform neuroimaging detection with buccal administration of 100 mmol/L NaCl.
|
NaCl in various concentrations was desorved in the test solutions in Salt_effect subgroups
|
Experimental: Salt_effect subgroup 3
The volunteers allocated to the arm will perform neuroimaging detection with buccal administration of 150 mmol/L NaCl.
|
NaCl in various concentrations was desorved in the test solutions in Salt_effect subgroups
|
Experimental: Salt_effect subgroup 4
The volunteers allocated to the arm will perform neuroimaging detection with buccal administration of 200 mmol/L NaCl.
|
NaCl in various concentrations was desorved in the test solutions in Salt_effect subgroups
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Neuroimaging changes of salty gustatory cortices
Time Frame: 45min
|
Buccal administration of test solution for five mins, and PET/CT scan after 40 mins
|
45min
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SATIETY-2
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Volunteers
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
University Hospital, Clermont-FerrandUnite de Nutrition Humaine UMR 1019- INRAE; Unite MetaGenoPolis INRAE; France...CompletedHealthy Volunteers | Frail VolunteersFrance
-
AstraZenecaCompletedHealthy Elderly Volunteers | Healthy Young VolunteersUnited States
-
Newcastle UniversityCompletedGI Glycaemic Index Healthy Volunteers | GL Glycaemic Load Healthy VolunteersUnited Kingdom
-
University Hospital, Clermont-FerrandInstitut de Médecine du Travail; UMR CNRS 6024, LaPSCoRecruiting
-
McMaster UniversityOntario Ministry of Health and Long Term Care; Canadian Red Cross; David BraleyCompleted
-
Medtronic Cardiac Rhythm and Heart FailureCompleted
Clinical Trials on Capsaicin
-
University of FloridaCompletedPain | FibromyalgiaUnited States
-
Nantes University HospitalRecruitingNeuropathic Pain | Coccyx Disorder | CoccygodyniaFrance
-
University of FloridaCompleted
-
NeurogesXCompletedHIV Infections | Pain | Peripheral Nervous System Diseases
-
Samyang Biopharmaceuticals CorporationCompletedPostherpetic Neuralgia | Peripheral Nerve InjuryKorea, Republic of
-
The University of Texas Health Science Center,...University of California, San FranciscoActive, not recruitingMigraine | Cluster Headache | Trigeminal Autonomic Cephalgia | Hemicrania Continua | Paroxysmal Hemicrania | SUNCT | Short-Lasting Unilateral Neuralgiform Headache With Conjunctival Injection and TearingUnited States
-
Hospital de MataróInstituto de Salud Carlos III; Consorci Sanitari del MaresmeRecruitingStroke | Oropharyngeal Dysphagia | Swallowing Disorder | Stroke, ComplicationSpain
-
Propella TherapeuticsCompletedPain | Osteoarthritis, KneeUnited States
-
Averitas Pharma, Inc.RecruitingPost Surgical Neuropathic PainUnited States, Spain, France, Netherlands, Poland, United Kingdom
-
Carilion ClinicChorda Pharma, Inc.Completed